Erratum by unknown
The Chernobyl Nuclear
Catastrophe: Unacknowledged
Health Detriment 
Baverstock and Williams (2006) rightly
recommended international long-term stud-
ies of all potential health effects among the
populations exposed to Chernobyl fallout. In
the meanwhile, data on post-Chernobyl
health detriment in the former Soviet Union
and exposed parts of Europe, including evi-
dence of association with such contami-
nation, are already accessible, mostly
electronically. Three mutually consistent
findings, in particular, challenge widely pub-
licized conclusions the World Health
Organization (WHO 2005a, 2005b) (after
approval by the International Atomic Energy
Agency), and the United Nations Scientific
Committee on the Effects of Atomic
Radiation (UNSCEAR 2000).
First, scientists from the Moscow
Kurchatov Institute presented physical evi-
dence that the dominant sources of energy
released by the exploding reactor were not
the officially assumed thermal explosions
(Fairlie and Sumner 2006) but rather very
low-yield nuclear chain reactions in heavy
elements, combined with chemical reac-
tions (Checherov 2006). Thus, contrary to
the assumed emission of 50 million Ci into
the atmosphere (i.e., an estimated 3.5% of
the radioactive inventory of the destroyed
fuel elements, leaving over 90% of it in the
“sarcophagus”), these scientists conclude a
26-fold larger release of radioactivity, leav-
ing no more than 10–15% of the inventory
behind. A 26-fold increase would mean
that population exposures from the world-
wide fallout was in fact more than an order
of magnitude larger than assumed by
UNSCEAR (2000). This would explain a
variety of observed health effects that are
not to be expected at currently assumed
doses (Committee Examining Radiation
Risks of Internal Emitters 2004; Fairlie and
Sumner 2006; Glushenko et al. 2006). 
Second, the WHO accepted the conclu-
sions by UNSCEAR that exposures of popu-
lations in the neighboring contaminated
regions were of the order of 10 mSv, except
for higher thyroid doses from 131I
(UNSCEAR 2000; WHO 2005a, 2005b).
The main contributions to dose in other tis-
sues—externally and internally—have been
assumed to come from 137Cs and 134Cs,
whereas exposures from other radioisotopes,
such as 90Sr and 239Pu, or other alpha
emitters were presumed negligible beyond
distances of about 100 km from the plant
(Fairlie and Sumner 2006; UNSCEAR
2000; WHO 2005a, 2005b).
However, direct biological dosimetry
contradicts these official estimates. Several
research teams investigated radiation-specific
cytogenic alterations in the lymphocytes
of about 1,000 exposed persons immedi-
ately after the accident and/or some years
later (Schmitz-Feuerhake 2006; Schmitz-
Feuerhake et al. 2006). The majority of
these studies revealed that the rate of unsta-
ble and stable chromosome aberrations was
about 10–100 times higher than would be
expected at UNSCEAR’s estimated exposure
levels (UNSCEAR 2000). Biological dosime-
try is, however, consistent with the evidence
for a much larger release of radioactivity in
the explosion. Furthermore, multiaberrant
cells, characteristic for incorporated alpha
emitters, were identified well beyond
100 km from Chernobyl, whereas pluto-
nium particles were found as far away as
Norway, contradicting “negligible exposure
levels” beyond 100 km [International
Physicians for the Prevention of Nuclear
War (IPPNW) 2006; Schmitz-Feuerhake
2006; Schmitz-Feuerhake et al. 2006].
Currently adopted models for Chernobyl
dose estimates ignore contributions from
alpha emissions even though they are known
to have relative biological effectiveness (RBE)
about 20 times larger than that of most
radioactive beta and gamma radiation (Fairlie
and Sumner 2006; International
Commission on Radiological Protection
1991; UNSCEAR 2000).
Third, excess infant (perinatal) mortal-
ity and teratogenic effects were observed in
Germany, Poland, and the former Soviet
Union shortly after the Chernobyl explo-
sion [European Committee on Radiation
Risk (ECRR) 2006; Gesellschaft für
Strahlenschutz/ECRR 2006; Körblein
1997, 2003; Scherb et al. 1999; Schmitz-
Feuerhake 2006]. Excess malformations,
childhood morbidity, and genetic effects
were reported from several areas of Central
Europe and Turkey (Committee Examining
Radiation Risks of Internal Emitters 2004;
ECRR 2006; Fairlie and Sumner 2006;
Körblein 2006; Scherb 2006; Schmitz-
Feuerhake 2006). These post-Chernobyl
observations are consistent with those in the
United Kingdom, the United States, and
West Germany following the atmospheric
nuclear bomb tests of the 1950s (Körblein
2004; Whyte 1992). According to the
International Commission on Radiological
Protection (1991), UNSCEAR (2000), and
other radiation authorities, teratogenic
effects should not occur below a dose
threshold of about 100 mSv. However, offi-
cial estimates of fetal doses after the
Chernobyl explosion, even in the most
contaminated regions of Germany, were
< 1 mSv (UNSCEAR 2000), far below the
presumed safe threshold. Thus, either the
fetus is much more sensitive to radiation
than officially assumed, or the estimated
post-Chernobyl fetal doses are far too low
(which is consistent with considerably
higher radioactive releases), or, most likely,
there is a combination of both.
In the absence of scientifically convinc-
ing evidence rebutting such challenges to
official assessments of the physical events
and long-term human consequences of the
Chernobyl catastrophe, the Precautionary
Principle in public health issues (Goldstein
1999; Kriebel et al.2001) requires that these
unwelcome findings be no longer ignored in
“state of knowledge” reviews (Brenner et al.
2003; National Research Council 2006), in
“assessments of the health consequences”
(Baverstock and Williams 2006), and in
official radiation protection standards.
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The Chernobyl Nuclear
Catastrophe: Baverstock and
Williams Respond
Nussbaum makes three points, namely that
on the basis of the “source term” for the
Chernobyl accident population, doses are
underestimated by a factor up to 26, that
Chernobyl dose estimates ignore exposure
to alpha emissions, and that excess perinatal
mortality and morbidity have been widely
observed outside the main contaminated
regions.
Nussbaum’s first point is pivotal because
it provides the rationale for the claims that
the health effects of the accident have been
underestimated. We are not aware that the
source term has been used in the estimation
of doses. It was not for the most affected
areas (Fairlie and Sumner 2006). As far as
Europe is concerned, doses from isotopes of
iodine and cesium have been estimated from
surveys of ground deposition. As recently as
2006, the doses for all of Western Europe
and much of Central and Eastern Europe
were reestimated by Cardis et al. (2006);
there is reasonable agreement between their
estimates and those made within a few
years of the accident [e.g., United Nations
Scientific Committee on the Effects of
Atomic Radiation (UNSCEAR) 1988]. We,
therefore, do not accept that population beta
and gamma doses from iodine and cesium
have been grossly underestimated.
We do not dispute Nussbaum’s argu-
ment that additional doses may have been
received from alpha emitters incorporated
internally and that these might have been
more than is acknowledged by UNSCEAR
and the World Health Organization
(WHO). Unfortunately the references
quoted by Nussbaum as showing that at
least 85% of the fuel was released are
abstracts that provide no supportive evi-
dence. It is generally accepted that about
3% of the nonvolatile elements present in
the reactor were released; while these were
mostly deposited close to the reactor, more
distant contamination also occurred. We
know of no reliable evidence that the major-
ity of the nonvolatile elements were released,
and it is accepted that a huge radioactive
lava-like mass of fuel remains in the reactor.
We are not qualified to comment on the
nature of the explosion, but that is hardly an
issue if the doses are correctly estimated.
We acknowledge that there have been
ecologic studies of increased perinatal mor-
bidity and mortality in areas where doses
were low (i.e., of the order of a few milli-
sieverts) (Korblein 2006), but other studies
have found no effect (e.g., Dolk et al. 1999;
Hausler et al. 1992). The much larger effects
that would be expected in populations much
closer to the accident, and thus more highly
exposed, are not accepted by the WHO and
International Atomic Energy Agency
(IAEA), and small increases have been
attributed to increased recording of minor
abnormalities. This does not mean that
there has been no effect, and that is one rea-
son why we have called for a comprehensive
health assessment of the accident (Williams
and Baverstock 2006). These effects were
not attributed to the Chernobyl accident by
either Fairlie and Sumner (2006) or the
Committee Examining Radiation Risks of
Internal Emitters (2004).
It is undoubtedly the case that some have
sought to downplay the importance of the
health consequences of the accident, the
WHO and the IAEA among them, but it is
also true that others have sought to inflate
the health consequences. Fairlie and Sumner
(2006) rightly point out the uncertainties
involved in reconstructing the accident and
thus the need for value judgments in making
health assessments. We have doubts about
some of the claims made in Nussbaum’s let-
ter, but by pointing out the discrepancies
between the views of some scientists and the
majority, he reinforces one of our main
points. The continuing disputes over the
consequences of the Chernobyl accident
make it essential that a major international
organization be created to support authorita-
tive studies of the long-term effects of the
world’s biggest nuclear accident.
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Chlorinated Pools and the Risk
of Asthma 
In a recent article, Bernard et al. (2006)
presented data that led them to conclude
that the use of chlorinated pools, especially
by young children, interacts with atopic sta-
tus to promote the development of child-
hood asthma. I question these conclusions
for several reasons.
First, this finding is not consistent with
the authors’ recent publication from this
same group of children (Nickmilder et al.
2005) concluding that children living in a
home cleaned with chlorine bleach had a
lower prevalence of asthma. It is difficult to
understand how occasional exposure to chlo-
rinated compounds at indoor swimming
pools could cause asthma if more frequent
and longer exposures at home were actually
protective. 
Second, the data presented by Bernard
et al. (2006) do not fully support their con-
clusion. For example, the exposure metric
they used to describe the children’s exposure
to chlorinated pools is the lifetime cumula-
tive swimming pool attendance (CPA) given
in hours. The CPA data are based on lifetime
exposure derived from questionnaires that
the parents of these 11- to 12-year-old chil-
dren completed at home [American Thoracic
Society, European Respiratory Society
(ATS/ERS) 2005] and is thus subject to
their understanding and interpreting the
question, as well as to recall bias. In addition,
systematic bias is introduced by using a life-
time cumulative measure like CPA to relate
exposure to asthma prevalence. Lifetime
cumulative exposure is obviously dependent
on the age of the child; because asthma
prevalence also increases during this same
time, the child’s age becomes a confounder
that cannot be dealt with adequately in the
analysis used by Bernard et al. (2006).
Third, the data presented to relate the
dose response between CPA and asthma
prevalence are confusing. In Table 2 of
Bernard et al. (2006), the relationship is not
significant, while in Figure 1 it is significant
in a subgroup. In their Figure 1A, a dose
response is suggested between CPA and the
prevalence of doctor-diagnosed and total
asthma, but only in those children whose
total IgE is > 100 IU/mL. The subgroups in
this figure are small; from data in Table 1 and
the text, it appears that only 14 children had
both IgE > 100 IU/mL and doctor-diagnosed
asthma, and only 20 had total asthma with a
high IgE concentration. Because Figure 1
(Bernard et al. 2006) divides all 341 children
into approximately equal quartiles of CPA, it
seems impossible to allocate the 14–20 chil-
dren with asthma in such a way that would
result in an asthma prevalence of 12–35%
within each quartile. I suggest that the figure
is drawn incorrectly and that the correct 
relationship is shown in their Table 2.
Fourth, insufficient information is avail-
able to address the uncertainties in the out-
come measures of Bernard et al. (2006). The
data in their Table 2 demonstrate that swim-
ming pool attendance was associated with
the prevalence of an elevated exhaled nitric
oxide (eNO); neither doctor-diagnosed
asthma nor total asthma was significantly
related to swimming pool attendance unless
combined with eNO measures. Although
eNO is associated with asthma, it has been
used primarily to measure the state of air-
way inflammation in asthma; the use of
eNO is less certain as a diagnostic tool
(ATS/ERS 2005). In fact, elevated eNO
levels have been associated with viral respi-
ratory tract infections, allergic rhinitis, and
sinusitis (ATS/ERS 2005). These condi-
tions were not included in the health ques-
tionnaire described by Bernard et al. (2006)
in their “Materials and Methods.” Indeed,
only 20 of the 29 children with an elevated
eNO (> 30 ppb) had doctor-diagnosed
asthma. In addition, the study was con-
ducted during winter months when viral
respiratory infections are common; there-
fore, the presence of these infections could
have produced outcome misclassification.
Finally, inhaled steroid medications
markedly reduce eNO, and use by these
children could have introduced yet another
reason for outcome misclassification. 
To summarize, the uncertainty in both
the exposure estimates and the outcome
measures, coupled with the conflicting out-
comes with home exposure to chlorine
bleach, make it difficult to accept the strong
conclusions reached by Bernard et al. (2006)
in their article.
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Chlorinated Pools: Bernard
et al. Respond
We are pleased to respond to Eggleston
because this offers us the opportunity to
respond to some of the criticisms that have
been formulated since we originally pro-
posed the pool chlorine hypothesis (Bernard
et al. 2003).
First, the divergent effects of chlorine
[described in our recent study (Bernard et al.
2006)]—when this chemical is used to clean
surfaces or to sanitize recreational water—are
not inconsistent. Chlorine is a nonspecific
biocide, and there are clearly situations in
which the beneficial effects of this agent need
to be balanced against its possible adverse
effects. As we explained in the “Discussion”
of our recent articles (Bernard et al. 2006;
Nickmilder et al. 2007), exposure conditions
are radically different when children live in a
house cleaned with bleach compared with
when they attend an indoor chlorinated
pool. When a house is cleaned with bleach,
children are not likely to be exposed to high
concentrations of chlorine gas or trichlo-
ramine because they are not directly involved
in the cleaning tasks. In that situation, the
balance for children—but not necessarily for
people doing the cleaning—is clearly in favor
of the beneficial effects of chlorine from a
decreased risk of asthma and respiratory
allergy (Bernard et al. 2006; Martyny et al.
2005; Nickmilder et al. 2007). In contrast,
when attending an indoor pool, children are
directly in contact with the chlorination
products that they actively inhale as gases,
aerosols, or even water. It can be argued that
the time children spend in a swimming pool
is limited, but we should not forget that
A 240 VOLUME 115 | NUMBER 5 | May 2007 • Environmental Health Perspectives
Correspondencechlorine-based chemicals are rapidly acting
oxidants, a property essential to their efficacy.
Eggleston raises the issue of a possible
confounding between age and lifetime cumu-
lative pool attendance (CPA). However,
because our study (Bernard et al. 2006)
focused on children in 5th and 6th grades,
there is little variation in age (range
10–13 years), explaining why age did not
emerge as a predictor of the outcomes
(Table 1) and also why it did not vary across
CPA categories (analysis of variance,
p = 0.35). Eggleston states that cases of
asthma cannot be allocated to the CPA cate-
gories of our Figure 1, but this is because he
has misinterpreted the way these categories
were constructed. Subjects were not divided
into quartiles but into predefined categories
of increasing CPA. If numbers of subjects
included in each category approximate those
of quartiles, this is no more the case when
each category is further divided according to
the total serum IgE. The reason for this is
given in Figure 3, which shows that the pro-
portion of children with higher serum IgE
gradually decreases as CPA increases.
We agree with Eggleston that the
exhaled nitric oxide (eNO) test is not a spe-
cific measure of airways inflammation in
asthma. Rhinitis is a potential confounder
that we took into account by adjusting the
odds ratios (ORs) for the sensitization to
aeroallergens, including house dust mites,
the most frequent allergen in allergic rhini-
tis. We did not retain medication for asthma
or allergy in the final analysis because of the
strong collinearity of this factor with some
outcomes, such as doctor-diagnosed asthma.
However, adding medication to the list of
possible predictors did not abolish the
association between eNO and CPA (OR,
1.32; 95% confidence interval, 1.09–1.60).
We also found no confounding by viral
infections, which is not surprising because
children seriously affected by a respiratory
illness were absent from schools at the time
of examination. 
We used objective measures whenever
possible in our study (Bernard et al. 2006),
but in order to derive predictors such as
CPA, we had no choice but to use the infor-
mation provided by parents and school
directors (for compulsory pool attendance at
school). We believe that the strong associa-
tions found in our study should not be dis-
missed as having arisen by bias or insufficient
adjustment. However, what makes us increas-
ingly confident in our observations is their
reproducibility. The findings reported in our
study (Bernard et al. 2006) confirm earlier
observations (Bernard et al. 2003), and a new
larger study on adolescents, just completed,
again brings to light quite strong associations
between different indicators of asthma and
CPA, especially among atopic children
(Bernard et al., unpublished data). 
The authors declare they have no competing
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ERRATUM
Demchuk et al. have reported two errors in their article [Environ Health Perspect
115:231–234 (2007)]. First, in the legend to Figure 1, the authors stated that the figure pre-
sented frequencies and odds ratios of “16 gene variants listed in Table 1.” However, only
the first group of 12 genes in Table 1 was taken into consideration to generate the figure.
This correction also requires a change on page 232
(20th line of “Results”) because fewer polygenotypes
are possible with this combination of 12 genes than
with 16 genes (65,536 polygenotypes). The corrected
sentence is as follows: 
Figure 1 summarizes the relationship between the frequency
of each of the 4,096 (212) potential genotypic profiles and
risk of developing asthma under the described model and
illustrates the concept that susceptibility variants can shift the
risk distribution to the right or left depending upon whether
the variant has an adverse or protective role, respectively. 
Second, the frequency distributions shown in Figure 2
were mistakenly weighted by single nucleotide poly-
morphism (SNP) frequencies for the population of
cases provided in each source study. Instead, the distri-
butions should have been weighted by SNP frequencies
from the controls in each source study, which approxi-
mate the SNP frequencies reported for the general
population. The corrected figure appears below.
These errors were introduced when new figures were
generated during the final revision of the paper. The
authors emphasize that these changes do not alter the
concepts that they addressed in their article. 
The authors apologize for the errors.
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Figure 2. Distribution of relative dis-
ease risk calculated using asthma-
associated gene variants grouped by
their biological attribution: (A) 12
group I variants only; (B) with three
group II variants added to (A); and (C)
with group III variant added to (B).